AZENTA INC
AZTA · NASDAQ
Updated at 2026-10-13 14:35:20
- Today's High
- $38.01
- Today’s Low
- $37.18
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $37.42
- Previous Close
- $37.77
- Volume
- 1.04M
- Market Cap
- $1.65B
- P/E Ratio
- --
- EPS
- $-2.66
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Life Sciences Tools & Services
- Sub-industry
- MEDICAL INSTRUMENTS & SUPPLIES
- Headquarters
- 200 SUMMIT DRIVE, BURLINGTON, MA, UNITED STATES, 01803
- Country
- US
- Listing Date
- 1995-02-02
- Fiscal Year End
- September
- Shares Outstanding
- 46.09M
- CIK
- 0000933974
- Website
- www.azenta.com
Azenta Inc. is a premier provider of sample management solutions and life science tools, dedicated to enhancing laboratory efficiencies within the biotechnology and pharmaceutical industries. The company excels in innovative automation and comprehensive biorepository services, facilitating faster drug discovery while ensuring adherence to stringent regulatory standards. With a forward-looking strategy that leverages advanced storage technologies and strategic partnerships, Azenta is uniquely positioned to seize growth opportunities in the expanding global life sciences market. Its commitment to pioneering scientific research through sophisticated innovations underscores its potential appeal to institutional investors seeking exposure in the dynamic life sciences sector.
Financial Metrics
Revenue
2026-06-30
$161.17M
2026-03-31
$144.79M
2025-12-31
$148.64M
2025-09-30
$159.19M
Operating Expenses
2026-06-30
$76.53M
2026-03-31
$77.32M
2025-12-31
$68.58M
2025-09-30
$69.33M
Net Income
2026-06-30
$2.45M
2026-03-31
-$160.79M
2025-12-31
-$15.43M
2025-09-30
$50.87M
Net Profit Margin
2026-06-30
1.52%
2026-03-31
-111.05%
2025-12-31
-10.38%
2025-09-30
31.95%
Earnings Per Share
2026-06-30
$0.16
2026-03-31
$-0.04
2025-12-31
$0.09
2025-09-30
$0.21
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$14.42M
2026-03-31
-$143.34M
2025-12-31
$11.58M
2025-09-30
$20.73M
Effective Tax Rate
2026-06-30
280.73%
2026-03-31
0.2%
2025-12-31
-151.94%
2025-09-30
-719.88%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $161.17M | $144.79M | $148.64M | $159.19M |
| Operating Expenses | $76.53M | $77.32M | $68.58M | $69.33M |
| Net Income | $2.45M | -$160.79M | -$15.43M | $50.87M |
| Net Profit Margin | 1.52% | -111.05% | -10.38% | 31.95% |
| Earnings Per Share | $0.16 | $-0.04 | $0.09 | $0.21 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $14.42M | -$143.34M | $11.58M | $20.73M |
| Effective Tax Rate | 280.73% | 0.2% | -151.94% | -719.88% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.